Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1800016132Phase 4Not yet recruiting
Phase 4, open-label, single-arm trial of esmolol in septic shock, sponsored by Yejishan Hospital of Wannan Medical College. Primary endpoint: Venous vascular tone. Planned start Jun 2018; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1800016132.